🇺🇸 FDA
Pipeline program

pemetrexed

8431

Phase 3 small_molecule completed

Quick answer

pemetrexed for Head and Neck Neoplasms is a Phase 3 program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly and Company
Indication
Head and Neck Neoplasms
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials